What was pitched as the "$20 biotech stock to hit $48" last Summer is now being touted as the next 1,000% gainer and their "Stock of the Decade"
17 Comments Read MoreArticles
What’s Cabot Small-Cap Confidential’s “Stock of the Decade?”
Cabot’s “$20 Biotech Stock to Hit $48” (Plus Some Personal Buys)
Cabot’s “$15 Health Care Stock to Hit $45”
Sniffing out a tease from Cabot's Small Cap Confidential -- one reader says, "I've never seen these guys so confident on a recommendation"
15 Comments Read MoreCabot Small-Cap’s “Next Medifast”
Sleuthing out the next 16,000% gainer (they think) teased by Cabot Small-Cap Confidential
13 Comments Read MoreCabot’s “Your Wealth in the Coming Era of Universal Connectivity”
I’ve been resisting writing about this stock that Cabot is teasing for almost a year for their Small-Cap Confidential newsletter (edited by Thomas Garrity) — I started getting very similar teaser ads from them last July, as best I can tell, and the ad has continued to roll on, with minor variations, almost constantly since […]
3 Comments Read MoreCabot Small-Cap Confidential
Looks for hidden small cap opportunities, claims a “limited circulation” because of generally small and less liquid investments. Formerly edited by Thomas Garrity for many years, Tyler Laundon came to Cabot in 2016 after writing for some Wyatt Research newsletters for several years.
3 Reviews Read MoreWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
I subscribe to Thomas Garrity at Cabot Small Cap and I must tell you it has made me a lot of money. I think he has only ...